New amfAR Cure Research Grants Enlist the Help of Bioengineers
amfAR grantee Dr. Keith JeromeIn a novel approach to conquering HIV, amfAR is pairing HIV researchers with bioengineers to address a key barrier to a cure for HIV: the persistent reservoirs of virus not cleared by antiretroviral therapy. A new round of amfAR Investment Grants, of up to $1.5 million each, will support six research projects aimed at finding ways to use highly advanced technologies originally developed in other research fields to clear HIV reservoirs.
“Over the past couple of decades, stunning advances in bioengineering have led to the development of new technologies and therapeutics that will likely have a profound impact on treating and eradicating diseases,” said amfAR CEO Kevin Robert Frost. “Many of these exciting new technologies have yet to be evaluated in the realm of HIV cure research, and we hope this new round of grants laysamfAR grantee Dr. Timothy Henrich the groundwork for some innovative approaches to a cure.”
The Investment awards provide up to $1.5 million to each research team over four years. They are part of amfAR’s $100 million Countdown to a Cure for AIDS initiative, which is aimed at developing the scientific basis of a cure by the end of 2020.
Bioengineers with expertise in cutting-edge technologies including microfluidics, gene-editing, nanotechnology, mass spectrometry, and single-cell magnetic levitation will work closely with leading HIV cure scientists to tackle some of the most intractable challenges in HIV cure research.
“This is a very exciting round of research grants that forges some unlikely but potentially groundbreaking scientific alliances,” said Rowena Johnston, Ph.D., amfAR vice president and director of research. “These highly innovative projects will undoubtedly move HIV cure research in some extraordinary new directions that, we hope, will get us closer to our goal.”
Read more about the grants and recipients.